Adverse events, short- and long-term outcomes of extra corporeal liver therapy in the intensive care unit: 16 years experience with MARS® in a single center

BACKGROUND: Molecular Adsorbent Recirculating System (MARS®) is a non-biological artificial liver device. The benefit risk ratio between uncertain clinical effects and potential adverse events remains difficult to assess. We sought to describe adverse events related to MARS® therapy as well as biolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Monet, Clément, De Jong, Audrey, Aarab, Yassir, Piron, Lauranne, Prades, Albert, Carr, Julie, Belafia, Fouad, Chanques, Gérald, Guiu, Boris, Pageaux, Georges-Philippe, Jaber, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484245/
https://www.ncbi.nlm.nih.gov/pubmed/36123713
http://dx.doi.org/10.1186/s13054-022-04165-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484245/
https://www.ncbi.nlm.nih.gov/pubmed/36123713
http://dx.doi.org/10.1186/s13054-022-04165-z

Ejemplares similares